在整个COVID-19疫苗接种时代,在癌症患者的PET/CT上挑战腹淋巴结
Alessia Giordano1, Rosj Gallicchio1, Mariarita Milella1
1Department of Nuclear Medicine, IRCCS CROB Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
Current pharmaceutical design
|March 8, 2024
概括
接种COVID-19疫苗可以在癌症患者中引起临时的下淋巴腺病变 (AxL),可能模仿PET/CT扫描中的转移. 仔细审查CT特征和患者病史对于准确诊断和避免不必要的治疗至关重要.
科学领域:
- 核医学是一种核医学.
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 接种COVID-19疫苗引发了人们对癌症患者意外检测到下淋巴腺病 (AxL) 的担忧.
- 良性疫苗接种后反应可能会干扰PET/CT成像 (F-18-FDG,F-18-Choline,Ga-68-DOTATOC),模仿转移.
- 本研究调查了癌症患者COVID-19疫苗接种后的PET/CT发现及其对疾病管理的影响.
研究的目的:
- 评估癌症患者在第一剂mRNACOVID-19疫苗接种后的PET/CT发现.
- 评估这些发现对癌症患者病程管理的影响.
主要方法:
- 对333名接受PET/CT疫苗接种后癌症患者 (研究组) 进行了评估.
- 如果SUVmax比率>1.5与逆侧淋巴结相比,则轴心淋巴结 (AxL) 的吸收被认为是显著的.
- 分析了淋巴结的共同注册的CT (Co-CT) 特征;结节的总成像阳性进行了进一步的调查.
主要成果:
- 17.1%的接种疫苗的患者在PET扫描上呈阳性淋巴结,明显高于疫情前对照组的2.8% (p < 0.001).
- 在接种疫苗的组中,84.2%的阳性淋巴结在同CT上表现出良性特征.
- 只有9名患者需要进一步评估,这表明大多数发现是疫苗接种后良性.
结论:
- 对PET/CT成像的准确解释至关重要,以防止在接种疫苗的癌症患者中误诊和不必要的干预.
- 将患者病史与PET/CT后淋巴结的CT分析结合起来,可以帮助区分良性疫苗反应与疾病进展.
相关概念视频
Radiological Investigation III: Pulmonary Angiogram and PET Scan
92
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
92
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K


